The numbers are sobering. Approximately 90% of drug candidates entering clinical trials never reach approval, and the average cost of bringing a single drug to market has climbed to around $2.6 billion when accounting for failures. For sponsors, every strategic decision carries real weight — including one that often doesn’t get the scrutiny it deserves: […]